Updated:
H1 Insights
H1 Insights sells AI tools to 18 of the top 20 pharma companies, converting physician data into enterprise SaaS for clinical trials and prescriber...
H1 Insights
H1 Insights occupies the intersection of healthcare data infrastructure and enterprise software, building an AI-powered platform designed to connect life sciences companies, payers, and providers with targeted physicians. The firm’s technology aggregates and verifies global healthcare professional data, surfacing expertise and clinical experience to answer questions around clinical trial site selection, thought-leader identification, and provider credentialing. Customers span pharma, payers, and digital health, with stated coverage across six continents. The platform is organized around distinct enterprise solutions: a clinical module accelerates patient recruitment and site selection, a medical module supplies real-time insights for medical affairs teams, and a commercial module enables data-driven prescriber engagement. Health plan clients use the data to automate provider directory accuracy, while digital health companies integrate H1’s intelligence to guide patients to in-network providers. The firm publicizes testimonials from Johnson & Johnson and BioMarin executives who cite efficiency gains in clinical operations. H1’s customer concentration in the top tier of global pharma anchors its scale. The firm states that an undisclosed total of leading payers and life sciences organizations partner with it, though precise revenue, deployment, and headcount figures remain private. Operations appear concentrated at the New York headquarters, with no additional offices disclosed on the primary website. Structurally, H1 fuses a data-compiling operation — aggregating doctor profiles, addresses, trial histories, and prescribing patterns — with a recurring SaaS revenue model aimed at regulated healthcare enterprises. By refusing to limit its intelligence to a single disease or drug class, the firm positions itself as an encyclopedic layer for provider data rather than a niche vertical tool, a posture that makes it a horizontal layer across the clinical, commercial, and payer workflows of the largest healthcare companies.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
How does H1 Insights source and verify its physician data?
H1 aggregates healthcare professional data from public records, licensure boards, publication databases, and proprietary verifications, then structures it with AI to maintain an up-to-date global view of doctors, their affiliations, and their clinical and research experience.
Which business units at a pharmaceutical company typically use H1’s platform?
Clinical operations teams use H1 for trial site selection and patient recruitment; medical affairs teams apply it for thought-leader mapping and engagement; commercial teams leverage it for prescriber identification and targeting — all from the same underlying provider dataset.
Does H1 enable compliance with provider data regulations for health plans?
H1 markets a dedicated health plan solution that automates provider directory management to support accuracy across network rosters, member directories, and internal systems — addressing the operational burden of regulatory requirements like CMS audit standards.
What is H1’s geographic reach?
The platform claims customers across six continents and positions physician data as global rather than country-specific, though the firm’s marketing and testimonials are heavily anchored in major US healthcare markets.
How does H1 differ from a clinical trial-focused site intelligence tool?
H1 applies its provider database across clinical, medical, commercial, payer, and digital health workflows rather than specializing in one segment. This cross-enterprise design allows the same physician intelligence to serve trial recruitment, thought-leader engagement, and prescriber targeting under one subscription.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: